SCHEMBL7203820

SCHEMBL7203820

CCCCCCCC/C=C\CCCCCCCC(O)OCC(O)CO

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.57
FAAH O00519 4/20 0.51
USP2 O75604 1/20 0.47
ALDH1A1 P00352 2/20 0.45
CNR1 P21554 1/20 0.45
CNR2 P34972 1/20 0.45
FFAR1 O14842 1/20 0.44
FFAR4 Q5NUL3 1/20 0.44
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
LMNA P02545 3/20 0.43
MAPT P10636 3/20 0.43
GMNN O75496 2/20 0.43
GLA P06280 2/20 0.43
POLB P06746 2/20 0.43
THRB P10828 2/20 0.43
CETP P11597 2/20 0.43
MAPK1 P28482 2/20 0.43
CXCR5 P32302 2/20 0.43
CCR6 P51684 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16254836 1.00 DGKA (0.57) DGKAFAAHUSP2ALDH1A1CNR1
SCHEMBL16277114 0.90 USP2 (0.56) DGKAUSP2FFAR1FFAR4MEN1
SCHEMBL17237491 0.90 USP2 (0.56) DGKAUSP2FFAR1FFAR4MEN1
SCHEMBL530879 0.90 USP2 (0.56) DGKAUSP2FFAR1FFAR4MEN1
SCHEMBL8401745 0.90 USP2 (0.56) DGKAUSP2FFAR1FFAR4MEN1
SCHEMBL14511078 0.90 USP2 (0.56) DGKAUSP2FFAR1FFAR4MEN1
SCHEMBL17677400 0.90 USP2 (0.56) DGKAUSP2FFAR1FFAR4MEN1
SCHEMBL3294751 0.88 USP2 (0.53) DGKAFAAHUSP2MEN1KMT2A
SCHEMBL16086045 0.88 DGKA (0.57) DGKAFAAHUSP2ALDH1A1CNR1
SCHEMBL10492009 0.88 DGKA (0.57) DGKAFAAHUSP2ALDH1A1CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1670436-B1 COMPOSITION COMPRISING ETHER LIPID CAMURUS AB (SE) 2013-11-20 EP claimed
CN-103314088-B Comprise the 1,3-dioxolanes-4-carbinol compound lubricant oil composite as anti-wear additive 雪佛龙奥伦耐有限责任公司 2016-06-22 CN disclosed
US-20090126602-A1 COLORANT COMPOSITIONS COMPRISING METATHESIZED UNSATURATED POLYOL ESTERS ELEVANCE RENEWABLE SCIENCES, INC. (US) 2009-05-21 US disclosed
US-20030134420-A1 Methods and compositions for gene delivery IMMUNE RESPONSE CORPORATION, THE 2003-07-17 US disclosed
WO-2001060415-A1 METHODS AND COMPOSITIONS FOR GENE DELIVERY THE IMMUNE RESPONSE CORPORATION (US) 2001-08-23 WO disclosed
US-5741337-A Process for the oxidative dyeing of keratinous fibres with a composition which contains an oxidation dye precursor, a coupler, and an oxidant at an acidic pH L'OREAL (FR) 1998-04-21 US disclosed
US-4736067-A DIRECT AND OXIDATION HAIR DYES L'OREAL (FR) 1988-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134420-A1 Methods and compositions for gene delivery POLRMT, NUP205, POLM DGKA 769/4885FAAH 4025/4885USP2 4101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.